Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent liver disorder globally, including in Asia-Pacific countries. In addition to contributing to severe liver disorders, MASLD increases the risk of various complications. Currently, resmetirom is the only U.S. Food and Drug...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for the Study of Obesity
2025-07-01
|
Series: | Journal of Obesity & Metabolic Syndrome |
Subjects: | |
Online Access: | http://www.jomes.org/journal/view.html?doi=10.7570/jomes25028 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|